D. E. Shaw & Co., Inc. Becton Dickinson & CO Call Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $730,851 - $799,953	3,300 Added 22.76%	17,800 $4.29 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $2.31 Million - $2.45 Million	-9,900 Reduced 40.57%	14,500 $3.59 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $2.3 Million - $2.65 Million	9,900 Added 68.28%	24,400 $5.95 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $3.7 Million - $4.11 Million	14,500 New	14,500 $3.75 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $1.02 Million - $1.13 Million	4,400 Added 28.21%	20,000 $4.86 Million
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $369,828 - $432,486	1,800 Added 13.04%	15,600 $3.38 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $2.34 Million - $2.76 Million	12,400 Added 885.71%	13,800 $2.95 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $261,645 - $278,460	1,400	1,400 $274,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.